Factor XIII Val34Leu polymorphism and risk of recurrent pregnancy loss in Iranian population: a case control study

• DOI: 10.1007/s11515-016-1419-x
• Publication Date: 2016-11-05T06:37:17Z
• Authors: Seyed Mehdi Sajjadi; Abbas Khosravi; Jalil Pakravesh; Zahra-soheila Soh...; Shahram Samiei; Saeed Mohammadi; Mohammad Ali Jala...
• Keywords: 0303 health sciences; 03 medical and health sciences; 3. Good health

Recurrent pregnancy loss (RPL) is a heterogeneous condition and thrombophilias have been considered as a probable cause. The aim of this study was to investigate the prevalence of the coagulation factor XIII Val34Leu polymorphism among women with unexplained RPL. A total of 140 women with a history of unexplained RPL and 100 age-matched healthy fertile women were recruited. The presence of FXIII Val34Leu polymorphism among the cases and controls was investigated using PCR-RFLP method. Genotype analyses of the subjects revealed that the patients had a significantly higher prevalence of V/L and L/L than the controls (P<0.05): 33.5% vs. 15%, and 9.2% vs. 2%, respectively. These results indicate a significant association between FXIII Val34Leu polymorphism and unexplained RPL in the Iranian patient.